Nalaganje...

Evaluation of Dosing Practices of Rivaroxaban and Dabigatran

Background: Anticoagulation is standard practice for the prevention and treatment of thromboembolic events. Two of the newer agents, rivaroxaban (Xarelto) and dabigatran (Pradaxa) are being utilized frequently in the inpatient and outpatient settings. Prescribers may not appreciate the need for dose...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Pharm Technol
Main Authors: Sieg, Adam, Nappi, Jean
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2015
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5990184/
https://ncbi.nlm.nih.gov/pubmed/34860911
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/8755122514567923
Oznake: Označite
Brez oznak, prvi označite!